$59.750
-0.807 (-1.35%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Bristol-Myers Squibb Company (BMY) Moving Averages Convergence Divergence (MACD) indicator is -1.27, suggesting BMY is Sell.
Bristol-Myers Squibb Company (BMY) 20-Day simple moving average is 60.44, while Bristol-Myers Squibb Company (BMY) share price is $—, making it Sell.
Bristol-Myers Squibb Company (BMY) 60-Day simple moving average is 63.54, while Bristol-Myers Squibb Company (BMY) share price is $—, making it Sell.
Technical Analysis for BMY
AI Technical BMYAs of 2026-10-17, the technical board for Bristol-Myers Squibb Company (BMY) reads sell: 4 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $59.75 sits below the 20-day and 60-day moving averages and above the 5-day, 10-day and 200-day.
Momentum readings: RSI stands at 40.31, MACD stands at -1.273 (Sell), Stochastic %K stands at 43.609, Stochastic %D stands at 41.298 and CCI stands at -66.605.
BMY trades below the 60-day SMA (63.54) and above the 200-day SMA (59.66). Immediate resistance sits at Classic R1 62.14, then R2 65.25. Support sits at Classic S1 56.04, then S2 53.05.
Bristol-Myers Squibb Company (BMY) Support & Resistance Level
Bristol-Myers Squibb Company (BMY) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 40.310 |
| STOCHk_14_3_3 | 43.609 |
| STOCHd_14_3_3 | 41.298 |
| CCI_20 | -66.605 |
| AO_5_34 | -3.120 |
| MOM_10 | -0.240 |
| MACD_12_26_9 | -1.273 |
Bristol-Myers Squibb Company (BMY) Relative Strength Index (RSI_14) is 40.310, creating a Neutral signal.
Bristol-Myers Squibb Company (BMY) Stochastic %K is 43.609, creating a Neutral signal.
Bristol-Myers Squibb Company (BMY) Stochastic %D is 41.298, creating a Neutral signal.
Bristol-Myers Squibb Company (BMY) CCI_20 is -66.605, creating a Neutral signal.
Bristol-Myers Squibb Company (BMY) Awesome Oscillator (AO) is -3.120, creating a Sell signal.
Bristol-Myers Squibb Company (BMY) Momentum (MOM) is -0.240, creating a Sell signal.
Bristol-Myers Squibb Company (BMY) Moving Average Convergence Divergence (MACD) is -1.273, creating a Sell signal.
Bristol-Myers Squibb Company (BMY) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 58.968 | Buy |
| MA_10 | 59.041 | Buy |
| MA_20 | 60.436 | Sell |
| MA_60 | 63.541 | Sell |
| MA_200 | 59.663 | Buy |
| MA_250 | 57.553 | Buy |
Bristol-Myers Squibb Company (BMY) 5-Day simple moving average is 58.968, while Bristol-Myers Squibb Company (BMY) share price is $, making it a Buy.
Bristol-Myers Squibb Company (BMY) 10-Day simple moving average is 59.041, while Bristol-Myers Squibb Company (BMY) share price is $, making it a Buy.
Bristol-Myers Squibb Company (BMY) 20-Day simple moving average is 60.436, while Bristol-Myers Squibb Company (BMY) share price is $, making it a Sell.
Bristol-Myers Squibb Company (BMY) 60-Day simple moving average is 63.541, while Bristol-Myers Squibb Company (BMY) share price is $, making it a Sell.
Bristol-Myers Squibb Company (BMY) 200-Day simple moving average is 59.663, while Bristol-Myers Squibb Company (BMY) share price is $, making it a Buy.
Bristol-Myers Squibb Company (BMY) 250-Day simple moving average is 57.553, while Bristol-Myers Squibb Company (BMY) share price is $, making it a Buy.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.